Clover Biopharmaceuticals, Ltd. announced that it received a resignation letter from Mr. Dong LYU on October 28, 2022 to resign as a non-executive Director with effect from October28, 2022. Since Lyu resigned as a non-executive Director, he ceases to be a member of the audit committee of the Company. Lyu tendered his resignation to focus on other business priorities.

The Board would like to announce that with effect from October 28, 2022, Mr. Xiang LIAO, an independent non-executive Director, has been appointed as a member of the Audit Committee.